Blocklisting Application and Total Voting Rights

RNS Number : 5817B
Judges Scientific PLC
31 January 2020
 

Judges Scientific plc

("Judges", the "Company" or the "Group")

Judges Scientific plc (the "Group" or "Judges")

Blocklisting Application and Total Voting Rights

 

The Group announces that it has today made an application to AIM for the block listing of 100,000 ordinary shares of 5 pence each in the Company ("Ordinary Shares"). These Ordinary Shares will be available to satisfy the future exercises of options over Ordinary Shares under the Company's Approved and Unapproved Share Option Schemes. These shares, when issued, will rank pari passu in all respects with the existing Ordinary Shares and it is expected that admission will occur on 7 February 2020.

 

Total Voting Rights

As at 3 February 2020 the total issued share capital has increased to 6,246,091 Ordinary Shares. There are no Ordinary Shares held in treasury. Each Ordinary Share carries voting rights on the basis of one vote per Ordinary Share. Therefore, the total number of voting rights in Judges Scientific is 6,246,091 Ordinary Shares.

The above figure may be used by shareholders as the denominator for calculations to determine if they have a notifiable interest in Judges Scientific under the Disclosure and Transparency Rules, or if such interest has changed. 

 

 

For further information please contact:

Judges Scientific



David Cicurel, CEO

Brad Ormsby, Group FD

Tel: +44 (0) 20 3829 6970


 

Shore Capital (Nominated Adviser & Broker)


Stephane Auton

Edward Mansfield

Sarah Mather

Tel: +44 (0) 20 7408 4090

 

Liberum (Joint Broker)

Bidhi Bhoma

Euan Brown

 

Media enquiries:

Alma PR (Financial Public Relations)

 

Tel : +44 (0) 20 3100 2222

Rebecca Sanders-Hewett

Sam Modlin

 

Tel: +44 (0) 20 3865 4219

judges@almapr.co.uk

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TVRWPUACGUPUGUG
UK 100

Latest directors dealings